Welcome to our dedicated page for MOBILE LADS news (Ticker: MOBO), a resource for investors and traders seeking the latest updates and insights on MOBILE LADS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MOBILE LADS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MOBILE LADS's position in the market.
MOBILE LADS, CORP. (OTC PINK: MOBO) announced a partnership with North Star Leasing to provide $25 million in equipment financing, specifically for EEG medical headsets, enabling healthcare providers in mental health and substance abuse to enhance clinical services. The average headset cost exceeds $30,000, and this financing will streamline the sales cycle from weeks to days, supporting $6 million revenue goals. North Star Leasing, a division of Peoples Bank (NASDAQ: PEBO), funded $135 million in 2022 and aims for $170 million in 2023. Avail targets 700 substance abuse clinics in Florida, emphasizing research in psychedelic medicine.
Avail Scientific Corp (OTC PINK: MOBO) aims to capitalize on the $1 billion substance abuse rehabilitation market in South Florida. The company anticipates capturing 5-7% of this market, potentially generating $6 million in annual revenues by providing EEG reports costing around $500 each. With approximately 3,500 patients being treated in the region, Avail Scientific is well-positioned for rapid growth in 2023. The company's subsidiary, Relai Neuro, will support this expansion by offering neurological testing and data management services to over 700 clinics in Florida.
MOBILE LADS, CORP. (OTC PINK:MOBO) announces its subsidiary, Relai Neuro, has been chosen as a vendor for Florida's Justice Administrative Commission (JAC). This partnership will provide essential electroencephalograms (EEGs), reports, and services, supporting the judicial system with critical medical evidence in criminal cases. The JAC oversees an annual budget of $1.07 billion. Relai Neuro specializes in neurological testing for mental health treatment centers. The CRO, Gerard Maynard, emphasizes the importance of this role for enhancing the court's ability to assess mental capacities, aiming to improve quality of life in Florida.
MOBILE LADS, CORP., operating as Avail Scientific (OTC PINK:MOBO), has appointed Gerard Maynard as the new Chief Revenue Officer. This announcement follows a January 10, 2023, Letter of Intent for acquiring Relai Neuro, where Maynard is presently the President. He brings over 20 years of experience in digital marketing, healthcare, and IT management, aiming to drive revenue growth in the neurological testing and mental health sectors. Maynard expressed enthusiasm about the potential for exponential growth in Avail's initiatives focusing on psychedelic medicine research and data management.
MOBILE LADS CORP, operating as AVAIL SCIENTIFIC (OTC PINK:MOBO), has announced the appointment of Dr. James Thompson as Interim CEO following the Letter of Intent to acquire Relai Neuro, where he serves as CEO. Dr. Thompson brings extensive experience in neurological testing and medical technology, aiming to strengthen Avail's mission in psychedelic medicine research. Current CEO Michael Paul will remain as President and Chairman. The acquisition aims to combine resources for developing treatments addressing addiction and mental health challenges. Avail is positioned to lead in providing data-driven solutions for effective therapeutic programs.
Avail Scientific (OTC PINK: MOBO) has signed a letter of intent to acquire Relai Neuro LLC, a Florida-based company specializing in neurological testing and data management. This acquisition aims to double Relai's sales force within three months and expand services into California, Texas, and Colorado. According to CEO Dr. James Thompson, the collaboration will enhance offerings and facilitate market expansion. Avail's CEO, Michael Paul, emphasizes that this acquisition will support their goal of leading in clinically studied psychedelic therapeutics for addiction and mental health, particularly through innovative methodologies for measuring treatment outcomes.
AVAIL SCIENTIFIC INC. (OTC PINK:MOBO) has appointed David Leonard as Head of Special Operations, aiming to enhance the company's therapeutic treatment development. With over 20 years of experience in logistics, education, and healthcare, Leonard is expected to drive research and operational projects, expediting product line transitions. The company has also filed a Certificate of Amendment with Nevada State, awaiting an updated symbol from FINRA.
MOBILE LADS, CORP. (OTC PINK:MOBO) has shifted its business focus to the Pharmaceutical Life Sciences sector, specifically targeting research and development of psychedelic medicines. This strategic direction aims to tackle chronic neurological disorders and mental health issues.
The company is currently evaluating partnerships with research institutions and manufacturing labs and plans to rebrand as Avail Scientific. This transition reflects a growing acceptance of psychedelics as a therapeutic option.
FAQ
What is the market cap of MOBILE LADS (MOBO)?
